About Pandemic Insights
Smarter Tools for
a Brighter Future.
Smart movement solutions to benefit us all.
As a company, we are determined to reduce the instance and impact
of infectious disease, starting with COVID-19 and its variants.
Pandemic Insights is combining proprietary algorithms, AI, machine
learning, and human behavior dynamics to power a revolutionary risk
assessment platform. Our Roamwell suite of products is destined to
help individuals, organizations, policymakers, and app developers to
manage hyperlocal infection risk.
Smart movement solutions to benefit us all.
As a company, we are determined to reduce the instance and impact of infectious disease, starting with COVID-19 and its variants.
Pandemic Insights is combining proprietary algorithms, AI, machine learning, and human behavior dynamics to power a revolutionary risk assessment platform. Our Roamwell suite of products is destined to help individuals, organizations, policymakers, and app developers to manage hyperlocal infection risk.

Why We Exist
infectious disease.

How We Do It
With smart movement tools that let people manage hyperlocal health risk.

The World We Want
A pandemic-free planet.

What We Stand For
To learn more, click on a letter below.
PRIVACY
personal privacy is necessary to success.
We believe the vigorous defense of personal privacy is necessary to success.
ACCESS
should be free and available to everyone.
We believe information that saves lives should be free and available to everyone.
CHOICE
choose.
We believe users adopt what users choose.
TRANSPARENCY
We believe trust comes naturally to
those with nothing to hide.
We believe trust comes naturally to those with nothing to hide.

The Pandemic Insights Team
We have enlisted some of the top minds in data science, public health
and infectious disease management.
We have enlisted some of the top minds in data science, public health and infectious disease management.
Eric Klasson
Pandemic Insights Founder and CEO
Mr. Klasson is an experienced entrepreneur and C-level executive responsible for leading multiple technology start-ups and companies through significant growth over his 35-year career. His early career included tenure at Price Waterhouse, PepsiCo, ConAgra and FoxMeyer Corporation. For the past decade, he has successfully focused on developing AI and machine learning technology solutions. Klasson specializes in technology commercialization, public/private research partnerships, and non-dilutive strategic partner financings. He has completed private and public debt and equity financings and has significant business development experience in international technology commercialization. His leadership roles include CFO, COO, President, and CEO.
Eric has served on multiple boards of non-profit and for-profit organizations. Eric received a Bachelor in Economics from the University of Michigan, an MBA from Texas A&M University, and completed USC’s Pharmaceutical Industry Executive Development Program. Eric has been actively involved in addressing food insecurity issues for over two decades. His work in this area includes non-profit director positions with the Monterey County Food Bank, Mobile Loaves & Fishes, and the Capital Area Food Bank and Capital Area Food Bank Foundation, where he served as its Chairman.


Albert C. Black, Jr.
Pandemic Insights Director
Mr. Black founded On-Target Supplies & Logistics, Ltd. (“On-Target”), a regional logistics management firm that provides outsourced services to a diverse set of companies. As Chairman of the Company, his primary responsibility is to oversee the executive management and strategy for On-Target and its affiliate companies TreCo Investments and READYTOWORK®, a workforce training and development company.
Mr. Black’s professional and civic experience includes serving in leadership positions with a diverse set of business, civic and education institutions. Mr. Black is a past Chairman of the Board of Trustees for the Baylor Health Care System. Mr. Black also serves as the inaugural chairman of the Charles A. Sammons Cancer Center Board. He is also a sponsoring trustee of the BHCS Diabetes Health and Wellness Institute.
Mr. Black has served as Dallas Regional Chamber Board Chairman, PrimeSource Board Chairman, and the Dallas Housing Authority Board Chairman. Mr. Black’s college and university board experience include St. Louis University Board of Trustees, Baylor University Regent, Texas Southern University Regent, and Paul Quinn College Regent.
Mr. Black received a bachelor’s degree from the University of Texas at Dallas and earned an MBA from the School of Business at Southern Methodist University.


Tracey Davies
Pandemic Insights Director
Ms. Davies is Chief Strategic Initiatives and Chief Intellectual Property Officer at Cancer Prevention and Research Institute of Texas. She has more than 20 years of experience advising life science companies at all stages of development, and research institutions, across a broad range of business and legal issues. Ms. Davies has represented clients in State and Federal Courts and in front of administrative tribunals throughout the United States, and has advised clients and led interdisciplinary trial teams managing disputes on a global basis. She is also a licensed patent attorney.
Ms. Davies has substantial law firm management experience and has served at all levels of firm management, leading law firm business and practice development efforts. Prior to joining CPRIT, she was a partner with Gibson Dunn & Crutcher L.L.P., where she co-chaired the firm’s Life Sciences industry practice. Previously, Davies was a partner and member of the Executive Management Committee at Vinson & Elkins, L.L.P., where she led the firm’s Intellectual Property, Technology and Life Science practices. Ms. Davies also serves on several non-profit and academic advisory councils, including for the Center for Entrepreneurial and Economic Innovation at the University of Texas at Arlington.
Davies received her J.D. from the University of Minnesota, where she also earned a master’s degree in Public Health.


Cindy M. Matula
Pandemic Insights Director
Ms. Matula is an experienced financial industry executive and trusted advisor to C-level
executives and Founders stemming from her 33-year career at J.P. Morgan Chase where she served in numerous leadership roles, ultimately serving as the Managing Director and Region Head of Central Texas Middle Market Banking in addition to Chairman of Austin Market Leadership.
Throughout her career, Ms. Matula served on numerous civic, not-for-profit and private school boards. She currently is a member of Austin Area Research Organization, Finance and Risk Committee of Austin Transportation Partnership and Advisory Board of Great Springs Project, Inc. Recognition she received includes Austin Business Journal’s Profile in Power and Distinguished Alumna of the year Texas Exes in Human Ecology.
Ms. Matula is a graduate of the University of Texas at Austin with a Bachelor of Science degree in Textiles & Clothing-Fashion Design and a Master of Business Administration.


Robert Campbell
Pandemic Insights Director
Mr. Campbell is founder and CEO of Campbell Global Service LLC. Campbell serves as Interim Chairman of the Board Executive Committee of the global East West Institute, the Lyndon Johnson School of Public Affairs, Austin Foreign Affairs Council, Access Health Care, Texas 2036, The Global Leaders Organization, and Tractus Corporation. Campbell previously spent 39 years with Deloitte & Touche, where he was a partner for 32 years, led the firm’s Public Sector practice for many years, co-founded the firm’s federal consulting practice, co-founded the firm’s Center for Health Innovation and Center for Cyber Solutions, and was a vice chairman of the firm. Campbell also served on the U.S. Federal Debt Commission of the Bipartisan Policy Center.
Mr. Campbell holds a BA degree with honors from Austin College, where he is in the Athletic Hall of Honor, and an MPA degree from the University of Texas at Austin’s LBJ School of Public Affairs, where he was the 2013 Distinguished Public Service Award honoree.


Barry Burgdorf
Pandemic Insights Director
Mr. Burgdorf is a partner at Hogan Lovells and has a multifaceted corporate practice in life sciences/biotech, healthcare, IT, software, and other technology markets as well as servicing clients in the higher education industry. As Vice-Chancellor and General Counsel of the University of Texas System for 9 years, Burgdorf regularly led its interactions with the federal government and oversaw areas that included legal, real estate, IT security, and technology transfer while serving as a member of UTS’s executive leadership team. He has been general counsel, outside counsel, and a c-level leader for both a life sciences and biotech venture capital fund and has served on numerous governing and advisory boards of technology and life sciences companies.
Mr. Burgdorf holds a BA degree in finance and international business from the University of Texas at Austin, an MBA from Southern Methodist University, and a JD from the University of Texas School of Law.


Dr. Stephen Klasson, MD
Dr. Stephen
Klasson, MD
Pandemic Insights Director
Dr. Klasson practices at Harbin Clinic, where he has been a Board Certified Orthopedic Hand Surgeon for 28 years. He has held multiple leadership roles, including serving as director on the boards of Harbin Clinic, Heritage First Bancshare, Surgery Center of Rome, and Harbin Properties. Since 1996, Dr. Klasson has been a member of both the American Society for Surgery of the Hand and the American Academy of Orthopaedic Surgeons. He holds a BA degree in History from Duke University and an MD from Vanderbilt University. Klasson is an investor in multiple privately-held manufacturing, professional services, and finance companies. He is also president of Health Creek Farm, LLC.


Harry Bushong
Pandemic Insights Director
Mr. Bushong is Founder and Managing Director of Convergence Ventures, a venture capital fund dedicated to driving growth and development of leading-edge software-based solutions in healthcare, life sciences, and artificial intelligence. In 2005, he co-founded nanoTox, Inc. to focus on providing toxicology services for companies using nano-scale technology across a wide range of industries. nanoTox has since morphed into Material Intellect, a new company that uses machine learning and other advanced tools to enhance the research capabilities of corporations, as well as academic and government laboratories. Harry has been an active investor in Advanced Throughput, Inc., a genomics company focused on personalized medicine (acquired by privately-held Bastra, Ltd.) and Optokey, Inc., a bio-spectroscopic and environmental analysis company.


Pandemic Insights meets the rigorous performance, scalability, security and compliance regulations of the largest enterprises.

